Show simple item record

dc.contributor.authorCalderon, G.
dc.contributor.authorCastaneda, C.A.
dc.contributor.authorCastillo, M.
dc.contributor.authorSanchez, J.
dc.contributor.authorBernabe, L.
dc.contributor.authorSuarez, N.
dc.contributor.authorTello, K.
dc.contributor.authorTorres, E.
dc.contributor.authorCotrina, J.M.
dc.contributor.authorDunstan, J.
dc.contributor.authorDe-La-Cruz, M.
dc.contributor.authorAbugattas, J.
dc.contributor.authorGuerra, H.
dc.contributor.authorManrique, H.E.
dc.contributor.authorAguayo, F.
dc.contributor.authorGomez, H.L.
dc.date.accessioned2025-10-31T18:33:27Z
dc.date.available2025-10-31T18:33:27Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.12805/4943
dc.description.abstractObjective: To evaluate the frequency distribution of viral infections in Peruvian Breast Cancer (BC) lesions and its association with clinicopathological features. Additionally, a prospective evaluation of p16 and Tumor-infiltrating lymphocytes (TIL) levels were performed for developing a comprehensive analysis. Methods: Detection of high risk- human papillomavirus (HR- HPV) through qPCR was performed in 447 BC and 79 non-cancer frozen samples. Paired paraffin samples from 238 BC were stained with Human cytomegalovirus (HCMV) and p16 immunohistochemistry. TIL was calculated in 397 BC cases. Results: HCMV was positive in 72.5%. HR- HPV was detected in 2.9% of BC and 1.3% of non-malignant samples. P16+ was found in 28.15% and median TIL percentage was 30. HR- HPV infection was associated with non-ductal histology (p=0.003) and p16+ (p=0.017). Positive P16+ was associated with higher T stage (p=0.022), grade (p=0.009), TIL level (p=0.002), and triple-negative phenotype (p=0.021). Conclusion: HCMV is frequent, but HR- HPV infection is unusual in Peruvian BC. P16+ is associated with HR- PVH infection, high TIL and aggressive features.en_US
dc.description.sponsorshipThis study was supported by CONCYTEC, under contracts #204-2015-FONDECYT and #198-2015-FONDECYT.
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherAsian Pacific Organization for Cancer Prevention
dc.relation.ispartofurn:issn:2476-762X
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectCervical Cancer Prevention and HPV Awarenessen_US
dc.subjectViral Associations in Breast Cancer Developmenten_US
dc.titleHuman Papillomavirus, Cytomegalovirus Infection and P16 Staining in Breast Tumors from Peruvian Womenen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.31557/APJCP.2022.23.5.1571
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.21
dc.type.otherResearch article
dc.identifier.journalAsian Pacific Journal of Cancer Prevention
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2